Edition:
United Kingdom

People: Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

167.22USD
23 Apr 2018
Change (% chg)

$0.24 (+0.14%)
Prev Close
$166.98
Open
$167.83
Day's High
$168.65
Day's Low
$165.69
Volume
58,605
Avg. Vol
98,361
52-wk High
$184.51
52-wk Low
$104.30

Kozarich, John 

Dr. John W. Kozarich is Non-Executive Independent Chairman of the Board of the Company. He has served as a member of Ligand’s board since March 2003. Dr. Kozarich is Chairman and President of ActivX Biosciences in La Jolla. From 1992 to 2001, he was vice president at Merck Research Laboratories and previously held professorships at the University of Maryland and Yale University School of Medicine. Dr. Kozarich is also an adjunct professor of Chemical Physiology at the Scripps Research Institute and serves on boards, including QLT, Inc., Corium Intl. and the Board of Trustees of the Gordon Research Conferences. He is also a recent recipient of the Distinguished Scientist Award from the San Diego Section of the American Chemical Society. Dr. Kozarich earned his BS in chemistry, summa cum laude, from Boston College, his PhD in biological chemistry from the Massachusetts Institute of Technology, and was an NIH Postdoctoral Fellow at Harvard.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 74,205
Long-Term Incentive Plans, USD --
All Other, USD 222,066
Fiscal Year Total, USD 296,271

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kozarich

296,271

Matthew Foehr

2,841,260

John Higgins

5,352,640

Matthew Korenberg

1,966,840

Charles Berkman

1,300,170

Nancy Gray

--
As Of  31 Dec 2016